Search

Mark Lance Shibuya

Supervisory Patent Examiner (ID: 18151, Phone: (571)272-0806 , Office: P/1677 )

Most Active Art Unit
1639
Art Unit(s)
1641, 1677, 1624, 1635, 1678, 1639, 1631, 1674
Total Applications
606
Issued Applications
223
Pending Applications
123
Abandoned Applications
283

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7183357 [patent_doc_number] => 20040203085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Method for parallel synthesis and transfer of molecules to a substrates' [patent_app_type] => new [patent_app_number] => 10/475801 [patent_app_country] => US [patent_app_date] => 2004-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7231 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20040203085.pdf [firstpage_image] =>[orig_patent_app_number] => 10475801 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/475801
Method for parallel synthesis and transfer of molecules to a substrates Apr 28, 2004 Abandoned
Array ( [id] => 7183130 [patent_doc_number] => 20040203046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Methods for modulating cellular and organismal phenotypes' [patent_app_type] => new [patent_app_number] => 10/832780 [patent_app_country] => US [patent_app_date] => 2004-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24724 [patent_no_of_claims] => 185 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20040203046.pdf [firstpage_image] =>[orig_patent_app_number] => 10832780 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/832780
Methods for modulating cellular and organismal phenotypes Apr 26, 2004 Abandoned
Array ( [id] => 915256 [patent_doc_number] => 07326954 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-05 [patent_title] => 'Scaffold-organized metal, alloy, semiconductor and/or magnetic clusters and electronic devices made using such clusters' [patent_app_type] => utility [patent_app_number] => 10/816603 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11214 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/326/07326954.pdf [firstpage_image] =>[orig_patent_app_number] => 10816603 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/816603
Scaffold-organized metal, alloy, semiconductor and/or magnetic clusters and electronic devices made using such clusters Apr 1, 2004 Issued
Array ( [id] => 6971718 [patent_doc_number] => 20050037428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Artificial receptors including reversibly immobilized building blocks, the building blocks, and methods' [patent_app_type] => utility [patent_app_number] => 10/812850 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 39306 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10812850 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/812850
Artificial receptors including reversibly immobilized building blocks, the building blocks, and methods Mar 28, 2004 Abandoned
Array ( [id] => 477969 [patent_doc_number] => 07223547 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-29 [patent_title] => 'Polypeptides having a functional domain of interest and methods of identifying and using same' [patent_app_type] => utility [patent_app_number] => 10/807856 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 89 [patent_no_of_words] => 28517 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223547.pdf [firstpage_image] =>[orig_patent_app_number] => 10807856 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/807856
Polypeptides having a functional domain of interest and methods of identifying and using same Mar 22, 2004 Issued
Array ( [id] => 836360 [patent_doc_number] => 07393318 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-01 [patent_title] => 'Methods and compositions for interaction trap assays' [patent_app_type] => utility [patent_app_number] => 10/801994 [patent_app_country] => US [patent_app_date] => 2004-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 52207 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/393/07393318.pdf [firstpage_image] =>[orig_patent_app_number] => 10801994 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/801994
Methods and compositions for interaction trap assays Mar 15, 2004 Issued
Array ( [id] => 7295882 [patent_doc_number] => 20040214183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Methods for global profiling gene regulatory element activity' [patent_app_type] => new [patent_app_number] => 10/468965 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12153 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214183.pdf [firstpage_image] =>[orig_patent_app_number] => 10468965 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/468965
Methods for global profiling gene regulatory element activity Mar 14, 2004 Abandoned
Array ( [id] => 377090 [patent_doc_number] => 07312190 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-25 [patent_title] => 'Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders' [patent_app_type] => utility [patent_app_number] => 10/802080 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 30 [patent_no_of_words] => 41529 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 425 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/312/07312190.pdf [firstpage_image] =>[orig_patent_app_number] => 10802080 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/802080
Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Mar 14, 2004 Issued
Array ( [id] => 7374714 [patent_doc_number] => 20040219580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Genome signature tags' [patent_app_type] => new [patent_app_number] => 10/791074 [patent_app_country] => US [patent_app_date] => 2004-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22491 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20040219580.pdf [firstpage_image] =>[orig_patent_app_number] => 10791074 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/791074
Genome signature tags Mar 1, 2004 Issued
Array ( [id] => 7184959 [patent_doc_number] => 20050191704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Assay devices utilizing chemichromic dyes' [patent_app_type] => utility [patent_app_number] => 10/790617 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9332 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191704.pdf [firstpage_image] =>[orig_patent_app_number] => 10790617 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/790617
Assay devices utilizing chemichromic dyes Feb 29, 2004 Abandoned
Array ( [id] => 7432884 [patent_doc_number] => 20040209860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity' [patent_app_type] => new [patent_app_number] => 10/778649 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64171 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209860.pdf [firstpage_image] =>[orig_patent_app_number] => 10778649 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/778649
Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity Feb 12, 2004 Abandoned
Array ( [id] => 7154050 [patent_doc_number] => 20050026172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'siRNA libraries optimized for predetermined protein families' [patent_app_type] => utility [patent_app_number] => 10/776399 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13240 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026172.pdf [firstpage_image] =>[orig_patent_app_number] => 10776399 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/776399
siRNA libraries optimized for predetermined protein families Feb 9, 2004 Abandoned
Array ( [id] => 7286862 [patent_doc_number] => 20040146922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Cellular arrays for the identification of altered gene expression' [patent_app_type] => new [patent_app_number] => 10/772167 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 43771 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146922.pdf [firstpage_image] =>[orig_patent_app_number] => 10772167 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/772167
Cellular arrays for the identification of altered gene expression Feb 3, 2004 Abandoned
Array ( [id] => 7308675 [patent_doc_number] => 20040142373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Cellular arrays for the identification of altered gene expression' [patent_app_type] => new [patent_app_number] => 10/772168 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 43774 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142373.pdf [firstpage_image] =>[orig_patent_app_number] => 10772168 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/772168
Cellular arrays for the identification of altered gene expression Feb 3, 2004 Abandoned
Array ( [id] => 7195721 [patent_doc_number] => 20050164211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Carbon nanotube molecular labels' [patent_app_type] => utility [patent_app_number] => 10/763674 [patent_app_country] => US [patent_app_date] => 2004-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9245 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164211.pdf [firstpage_image] =>[orig_patent_app_number] => 10763674 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/763674
Carbon nanotube molecular labels Jan 21, 2004 Abandoned
Array ( [id] => 7677692 [patent_doc_number] => 20040152134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Bicyclic melanocortin-specific compounds' [patent_app_type] => new [patent_app_number] => 10/761889 [patent_app_country] => US [patent_app_date] => 2004-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20227 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152134.pdf [firstpage_image] =>[orig_patent_app_number] => 10761889 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/761889
Bicyclic melanocortin-specific compounds Jan 20, 2004 Issued
Array ( [id] => 7447200 [patent_doc_number] => 20040186079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Methods for diagnosis and treatment of PH domain signal transduction disorders' [patent_app_type] => new [patent_app_number] => 10/738259 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22378 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20040186079.pdf [firstpage_image] =>[orig_patent_app_number] => 10738259 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/738259
Methods for diagnosis and treatment of PH domain signal transduction disorders Dec 17, 2003 Issued
Array ( [id] => 7332990 [patent_doc_number] => 20040131544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'In vivo imaging' [patent_app_type] => new [patent_app_number] => 10/739828 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11869 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20040131544.pdf [firstpage_image] =>[orig_patent_app_number] => 10739828 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/739828
In vivo imaging Dec 17, 2003 Abandoned
Array ( [id] => 7275600 [patent_doc_number] => 20040235051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Artificial receptors including amino acid derived building blocks and methods of making and using them' [patent_app_type] => new [patent_app_number] => 10/727059 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 29615 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235051.pdf [firstpage_image] =>[orig_patent_app_number] => 10727059 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/727059
Artificial receptors including amino acid derived building blocks and methods of making and using them Dec 1, 2003 Abandoned
Array ( [id] => 7412244 [patent_doc_number] => 20040106680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Use of creatine or creatine analogs for the treatment of diseases of the nervous system' [patent_app_type] => new [patent_app_number] => 10/718846 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11547 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106680.pdf [firstpage_image] =>[orig_patent_app_number] => 10718846 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/718846
Use of creatine or creatine analogs for the treatment of diseases of the nervous system Nov 20, 2003 Issued
Menu